A Risk-Benefit Assessment of Serotonin 5-HT Receptor Antagonists in Antineoplastic Therapy-Induced Emesis

By Perez E.A.  

Drug Safety, Vol. 18, Iss. 1, 1998-01 ,pp. : 43-56

Adis International

Access to resources Recommend Favorite

Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis

By Grunberg Steven M   Koeller James M  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2297-2303

Informa Healthcare

Access to resources Recommend Favorite

5-HT Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Comparison of Their Pharmacology and Clinical Efficacy

By Gregory R.E.   Ettinger D.S.  

Drugs, Vol. 55, Iss. 2, 1998-02 ,pp. : 173-189

Adis International

Access to resources Recommend Favorite

Action of 5-HT 3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew)

By Sam T.S.W.   Cheng J.T.Y.   Johnston K.D.   Kan K.K.W.   Ngan M.P.   Rudd J.A.   Wai M.K.   Yeung J.H.K.  

European Journal of Pharmacology, Vol. 472, Iss. 1, 2003-07 ,pp. : 135-145

Elsevier

Access to resources Recommend Favorite

Serotonin 5-HT7 Receptor Antagonists

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 3, 2004-09 ,pp. : 203-214

Bentham Science Publishers

Access to resources Recommend Favorite